HF2476

Over-the-counter allergy medicine sale restrictions modified.
Legislative Session 94 (2025-2026)

Related bill: SF3087

AI Generated Summary

Purpose of the Bill

The purpose of this bill is to modify the restrictions on the sale and purchase of certain over-the-counter (OTC) allergy medicines, specifically those containing methamphetamine precursor drugs like ephedrine and pseudoephedrine.

Main Provisions

  • Sale Restrictions: The bill places limits on the amount of methamphetamine precursor drugs that can be sold in a single OTC transaction. No more than two packages or a total weight of six grams of the precursor drugs can be sold in one sale.

  • Purchase Limits: Individuals cannot acquire more than seven grams of methamphetamine precursor drugs within a 30-day period through OTC sales.

  • Display and Sales Authorization: Methamphetamine precursor drugs must be displayed behind a checkout counter and sold only by a licensed pharmacist, pharmacy technician, or pharmacy clerk. Buyers must provide photographic identification and sign a record of the sale, which must be kept for three years.

  • Age Restrictions: It is prohibited to sell methamphetamine precursor drugs to individuals under 18 years old. Sellers have a defense if they reasonably relied on proof of age.

  • Criminal Penalties: Violators of these restrictions may face a misdemeanor charge, with potential imprisonment up to 90 days or a fine up to $1,000, or both.

  • Protection for Businesses: Business owners and supervisors are protected from criminal penalties if an employee violates these provisions without their knowledge, and if a training program was provided on relevant laws.

  • Exemptions: Certain products are exempt from these restrictions, including pediatric products for children under 12, certified methamphetamine-resistant products, gel capsule or liquid forms, and products where pseudoephedrine is less than 1% of total weight.

  • Record Keeping and Reporting: Employees must report suspicious transactions involving precursors, with protection from civil liability for good-faith reports.

Significant Changes to Existing Law

  • Local Ordinance Preemption: This bill preempts any local ordinances regulating the sale of products containing ephedrine or pseudoephedrine, making those enacted prior to this bill void.

Relevant Terms

  • Methamphetamine precursor drugs
  • Ephedrine
  • Pseudoephedrine
  • Over-the-counter (OTC) sale
  • Pharmacist
  • Misdemeanor
  • Pediatric products
  • Drug purchase limits
  • Sale restrictions
  • Local ordinance preemption

Bill text versions

Showing the most recent version. There are  2  total versions. You must be logged in  to view additional bill text versions.

Actions

DateChamberWhereTypeNameCommittee Name
March 17, 2025HouseActionIntroduction and first reading, referred toHealth Finance and Policy

Citations

You must be logged in  to view citations.

Progress through the legislative process

17%
In Committee
Loading…